93: The Results of 30 Years of Patients Receiving Active Surveillance Instead of Surgery; Dr. Akira Miyauchi from Kuma Hospital in Kobe, Japan
The result of over 1000 cases of active surveillance shows no resulting deaths of patients who choose no surgery for thyroid cancer Dr. Akira Miyauchi
92: Your Patient Type May Determine Your Thyroid Cancer Treatment → Dr. Michael Tuttle from Sloan Kettering
What type of patient are you, a minimalist or maximalist? About Dr. Tuttle, in his words: I am a board-certified endocrinologist who specializes in caring for
89: Thyroid Cancer Web Sites Confuse Patients with Dr. Rashika Bansal from St. Joseph’s Regional Medical Center
In this episode Dr. Bansal shares the research she presented at AACE 2017 and ENDO 2017, regarding the poor readability scores for thyroid cancer web sites.
The challenge for these web sites and health institutions is to translate thyroid education from complex to simple and easy to understand. Currently, many patients are not following up with treatment, citing confusion after being exposed to the various thyroid cancer education resources.
88: Has anything changed in the past 50 years of treating thyroid disease? (including thyroid cancer) The answer is yes. → Dr. Leonard Wartofsky from MedStar
Thyroid replacement therapy has been around since 1891, when patients were served sheep thyroid tartar. Now, patients have the convenience of a taking a simple
85: A Summary of Radioactive Iodine Treatment for Thyroid Cancer, with Dr. Alan Waxman from Cedars Sinai
Not all thyroid cancer patients who receive a thyroidectomy require radioactive iodine, but for those whose cancer maybe more aggressive and spread beyond the thyroid area, often radioactive iodine (RAI) is protocol.
RAI treatment may vary depending on the hospital.
In this interview, Dr. Alan Waxman explains what occurs leading up to, during, and after RAI. Topics discussed include:
If staying at the hospital after taking RAI, how long is the stay required?
Should you go home after RAI?
What is the benefit of staying overnight at the hospital when receiving RAI?
Worldwide trends toward prescribing lower doses of RAI.
Is there risk in RAI causing leukemia?
60% of people in the U.S. have thyroid nodules, and almost all are benign — the others maybe reason for concern. M. Regina Castro, MD